Eva Axén

N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors

Tjeerd Barf, Fredrik Lehmann, Kristin Hammer et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 107 citations · Full text

Lipid Synthesis, Biochemistry, Medicine +6

Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target

Fredrik Lehmann, Saba Haile, Eva Axén et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 83 citations · Full text

Obesity, Metabolic Syndrome, Potential Type 2 +8

Liver mitochondrial cytochrome P450 CYP27 and recombinant-expressed human CYP27 catalyze 1 alpha-hydroxylation of 25-hydroxyvitamin D3.

Eva Axén, Hans Postlind, H. E. Sjöberg et al. · Proceedings of the National Academy of Sciences · 1994 · 65 citations · Full text

Oxidative Stress, Mitochondrial Cyp27, Molecular Pharmacology +16

Substituted benzylamino-6-(trifluoromethyl)pyrimidin-4(1H)-ones: a novel class of selective human A-FABP inhibitors

Rune Ringom, Eva Axén, J. Uppenberg et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 65 citations · Full text

Medicinal Chemistry, Drug Target, Biochemistry +9

Cloning, Structure, and Expression of a cDNA Encoding Vitamin D325-Hydroxylase

Hans Postlind, Eva Axén, Tomas Bergman et al. · Biochemical and Biophysical Research Communications · 1997 · 42 citations

Biosynthesis, Cellular Enzymology, Biochemistry +6